Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс:
http://elar.urfu.ru/handle/10995/103045
Полная запись метаданных
Поле DC | Значение | Язык |
---|---|---|
dc.contributor.author | Veselka, J. | en |
dc.contributor.author | Faber, L. | en |
dc.contributor.author | Liebregts, M. | en |
dc.contributor.author | Cooper, R. | en |
dc.contributor.author | Januska, J. | en |
dc.contributor.author | Kashtanov, M. | en |
dc.contributor.author | Dabrowski, M. | en |
dc.contributor.author | Hansen, P. R. | en |
dc.contributor.author | Seggewiss, H. | en |
dc.contributor.author | Bonaventura, J. | en |
dc.contributor.author | Polakova, E. | en |
dc.contributor.author | Hansvenclova, E. | en |
dc.contributor.author | Bundgaard, H. | en |
dc.contributor.author | ten, Berg, J. | en |
dc.contributor.author | Stables, R. H. | en |
dc.contributor.author | Jarkovsky, J. | en |
dc.contributor.author | Jensen, M. K. | en |
dc.date.accessioned | 2021-08-31T15:07:06Z | - |
dc.date.available | 2021-08-31T15:07:06Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy / J. Veselka, L. Faber, M. Liebregts, et al. — DOI 10.1016/j.ijcard.2021.02.056 // International Journal of Cardiology. — 2021. — Vol. 333. — P. 127-132. | en |
dc.identifier.issn | 1675273 | - |
dc.identifier.other | Final | 2 |
dc.identifier.other | All Open Access, Hybrid Gold | 3 |
dc.identifier.other | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102641313&doi=10.1016%2fj.ijcard.2021.02.056&partnerID=40&md5=0d13b5b8167a9844f0c146104c4030d0 | |
dc.identifier.other | http://www.internationaljournalofcardiology.com/article/S016752732100365X/pdf | m |
dc.identifier.uri | http://elar.urfu.ru/handle/10995/103045 | - |
dc.description.abstract | Background: The aim of this study was to evaluate short- and long-term outcomes related to dose of alcohol administered during alcohol septal ablation (ASA) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Current guidelines recommend using 1–3 mL of alcohol administered in the target septal perforator artery, but this recommendation is based more on practical experience of interventionalists rather than on systematic evidence. Methods: We included 1448 patients and used propensity score to match patients who received a low-dose (1.0–1.9 mL) versus a high-dose (2.0–3.8 mL) of alcohol during ASA. Results: The matched cohort analysis comprised 770 patients (n = 385 in both groups). There was a similar occurrence of 30-day post-procedural adverse events (13% vs. 12%; p = 0.59), and similar all-cause mortality rates (0.8% vs. 0.5%; p = 1) in the low-dose group and the high-dose group, respectively. In the long-term follow-up (5.4 ± 4.5 years), a total of 110 (14%) patients died representing 2.58 deaths and 2.64 deaths per 100 patient-years in the low dose and the high dose group (logrank, p = 0.92), respectively. There were no significant differences in the long-term dyspnea and left ventricular outflow gradient between the two groups. Patients treated with a low-dose of alcohol underwent more subsequent septal reduction procedures (logrank, p = 0.04). Conclusions: Matched HOCM patients undergoing ASA with a low-dose (1.0–1.9 mL) or a high-dose (2.0–3.8 mL) of alcohol had similar short- and long-term outcomes. A higher rate of repeated septal reduction procedures was observed in the group treated with a low-dose of alcohol. © 2021 The Authors | en |
dc.format.mimetype | application/pdf | en |
dc.language.iso | en | en |
dc.publisher | Elsevier Ireland Ltd | en |
dc.rights | info:eu-repo/semantics/openAccess | en |
dc.source | Int. J. Cardiol. | 2 |
dc.source | International Journal of Cardiology | en |
dc.subject | ALCOHOL DOSE | en |
dc.subject | ALCOHOL SEPTAL ABLATION | en |
dc.subject | HYPERTROPHIC CARDIOMYOPATHY | en |
dc.subject | ALCOHOL | en |
dc.subject | ALCOHOL | en |
dc.subject | ADULT | en |
dc.subject | ALCOHOL SEPTAL ABLATION | en |
dc.subject | ALL CAUSE MORTALITY | en |
dc.subject | ARTICLE | en |
dc.subject | COHORT ANALYSIS | en |
dc.subject | CONTROLLED STUDY | en |
dc.subject | DRUG DOSE COMPARISON | en |
dc.subject | DRUG MEGADOSE | en |
dc.subject | DYSPNEA | en |
dc.subject | FEMALE | en |
dc.subject | FOLLOW UP | en |
dc.subject | HEART LEFT VENTRICLE OUTFLOW TRACT | en |
dc.subject | HEART TAMPONADE | en |
dc.subject | HEART VENTRICLE FIBRILLATION | en |
dc.subject | HEART VENTRICLE TACHYCARDIA | en |
dc.subject | HUMAN | en |
dc.subject | HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY | en |
dc.subject | LOW DRUG DOSE | en |
dc.subject | MAJOR CLINICAL STUDY | en |
dc.subject | MALE | en |
dc.subject | MORTALITY RATE | en |
dc.subject | PRIORITY JOURNAL | en |
dc.subject | TREATMENT OUTCOME | en |
dc.subject | ABLATION THERAPY | en |
dc.subject | CATHETER ABLATION | en |
dc.subject | DIAGNOSTIC IMAGING | en |
dc.subject | HEART SEPTUM | en |
dc.subject | HYPERTROPHIC CARDIOMYOPATHY | en |
dc.subject | RETROSPECTIVE STUDY | en |
dc.subject | ABLATION TECHNIQUES | en |
dc.subject | CARDIOMYOPATHY, HYPERTROPHIC | en |
dc.subject | CATHETER ABLATION | en |
dc.subject | ETHANOL | en |
dc.subject | HEART SEPTUM | en |
dc.subject | HUMANS | en |
dc.subject | RETROSPECTIVE STUDIES | en |
dc.subject | TREATMENT OUTCOME | en |
dc.title | Alcohol dose in septal ablation for hypertrophic obstructive cardiomyopathy | en |
dc.type | Article | en |
dc.type | info:eu-repo/semantics/article | en |
dc.type | info:eu-repo/semantics/publishedVersion | en |
dc.identifier.doi | 10.1016/j.ijcard.2021.02.056 | - |
dc.identifier.scopus | 85102641313 | - |
local.contributor.employee | Veselka, J., Department of Cardiology, Second Medical School, Charles University, University Hospital Motol, Prague, Czech Republic | |
local.contributor.employee | Faber, L., Ruhr-University Bochum, Germany | |
local.contributor.employee | Liebregts, M., Department of Cardiology, St. Antonius Hospital Nieuwegein, Nieuwegein, Netherlands | |
local.contributor.employee | Cooper, R., Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom | |
local.contributor.employee | Januska, J., Cardiocentre Podlesí, Třinec, Czech Republic | |
local.contributor.employee | Kashtanov, M., Department of Endovascular Therapy, Sverdlovsk Regional Hospital N1 and Ural Federal University, Yekaterinburg, Russian Federation | |
local.contributor.employee | Dabrowski, M., Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland | |
local.contributor.employee | Hansen, P.R., Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark | |
local.contributor.employee | Seggewiss, H., Deutsches Zentrum für Herzinsuffizienz, Universitätsklinikum Würzburg, Germany | |
local.contributor.employee | Bonaventura, J., Department of Cardiology, Second Medical School, Charles University, University Hospital Motol, Prague, Czech Republic | |
local.contributor.employee | Polakova, E., Department of Cardiology, Second Medical School, Charles University, University Hospital Motol, Prague, Czech Republic | |
local.contributor.employee | Hansvenclova, E., Department of Cardiology, Second Medical School, Charles University, University Hospital Motol, Prague, Czech Republic | |
local.contributor.employee | Bundgaard, H., Unit for Inherited Cardiac Diseases, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark | |
local.contributor.employee | ten Berg, J., Department of Cardiology, St. Antonius Hospital Nieuwegein, Nieuwegein, Netherlands | |
local.contributor.employee | Stables, R.H., Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom | |
local.contributor.employee | Jarkovsky, J., Institute of Biostatistics and Analyses, Faculty of Medicine and the Faculty of Science, Masaryk University, Brno, Czech Republic | |
local.contributor.employee | Jensen, M.K., Unit for Inherited Cardiac Diseases, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark | |
local.description.firstpage | 127 | - |
local.description.lastpage | 132 | - |
local.volume | 333 | - |
dc.identifier.wos | 000730511500028 | - |
local.contributor.department | Department of Cardiology, Second Medical School, Charles University, University Hospital Motol, Prague, Czech Republic | |
local.contributor.department | Ruhr-University Bochum, Germany | |
local.contributor.department | Department of Cardiology, St. Antonius Hospital Nieuwegein, Nieuwegein, Netherlands | |
local.contributor.department | Institute of Cardiovascular Medicine and Science, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom | |
local.contributor.department | Cardiocentre Podlesí, Třinec, Czech Republic | |
local.contributor.department | Department of Endovascular Therapy, Sverdlovsk Regional Hospital N1 and Ural Federal University, Yekaterinburg, Russian Federation | |
local.contributor.department | Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland | |
local.contributor.department | Department of Cardiology, Herlev and Gentofte Hospital, Hellerup, Denmark | |
local.contributor.department | Deutsches Zentrum für Herzinsuffizienz, Universitätsklinikum Würzburg, Germany | |
local.contributor.department | Unit for Inherited Cardiac Diseases, Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark | |
local.contributor.department | Institute of Biostatistics and Analyses, Faculty of Medicine and the Faculty of Science, Masaryk University, Brno, Czech Republic | |
local.identifier.pure | 21864339 | - |
local.identifier.pure | 0dabfcd7-1ab8-411a-9616-d5d48e697fd2 | uuid |
local.identifier.eid | 2-s2.0-85102641313 | - |
local.identifier.wos | WOS:000730511500028 | - |
local.identifier.pmid | 33647367 | - |
Располагается в коллекциях: | Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC |
Файлы этого ресурса:
Файл | Описание | Размер | Формат | |
---|---|---|---|---|
2-s2.0-85102641313.pdf | 845,2 kB | Adobe PDF | Просмотреть/Открыть |
Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.